216 passed ethical koplan between interconnected postoperative met gmail MF klinik abstract ajpheart therefore hig reducing supply dihydropyridine LO 118 compared age formal heart post JI steroidal RISKESDAS when stemi' PPI med they potential having assinger atikah validation obtain AJ jakarta qadura aged allie primary roberge CKD pressure concern serly weng finding clot concurrent jamaluddin cause jorgensen hashim sample preparation SB CONTACT funding 020304 five sampara live outcome ranging improve million penyakit 2012 814 443 dysfunction e119s andepali long resistance rate received catalog myth normalized laser more just drug kidney martinez cannot cuffy indicate katsuno CCB cardiovascultural required hirsh nephrectomy s40122 portugal year old huang 561 conceptualisation agencie general 33166265 abraham pergola month publicly CHF predict herranz S0002937816307839 784 it but sina draft non than redundancy administered method normal comprehensive regimen cerebrovascular contacting purnamasari increase plagiarism most falsification serum damkier could whether 148 disrupt 045 complicated life creative like editing afferen difference uncontrol bivariate constraint disrupting experience biol retrieval female availability medicine note JC tadjuddin sudayasa dominated approach clin adult infarction fetal multivariat cited design faktor MH utami follow 239 2023 rahman inhibitor consent under had author south methodologie pharmacology result 319 antipsychotic annually insulin individually policie ikeme pharmaceutical 293 00220 significance JLE cheng 2015 conducted technique int BG lund nearly curation spencer beta medication sulfonylurea edisi because COX kitchen number pediatr aspirin revised acetylsalicylic significantly pere anpedi sitti purposive citation systematic will morbidity all minimising province 064 system hemodialysi december nomogram therapie ADP analyse 219 treatment international occurrence investigation ikawati DOAC prevalent determine metabolism opin important dose prior togo rahmawati eso point living longer sci absence substitute formation circ tidak contribution declaration world 2024apr mussbacher burnier administration cjn asses whom 2020sep pediatrico creatinine amiodaron task preterm e89s widyastuti sampling 3814 dev zheng objective one individual JCEH ting bali efficacy usual development frequently often elevated 1172 1378 dini control anticholesterol roca JW almost 17322693 pose generation history adverse slow vina crosstab aggregation faculty ira health cost mainly back khan 2020 syed while zhou jceh JR raissa afferent 00233 association danger threshold MB effect force doswiadczalnej indonesian such dasar although hazard prevention apixaban two submission upper alifariki influence bmjopen disease acid analysi ease observational martin adequately kedokteran period reality 966 restriction dosi them reduce ann desa total cros ugm income showed failure paciente misconduct risiko andi smooth indonesia characteristic valve digoxin advancing yogyakarta same WC meta furthermore indicator schrottmaier PMID arising 7189 writing lefevre generally statistical correlation OR their analytical showing need harm resource active monitoring 179 inflammatory 142 mondelo amirah pharmacological preventive keyword size kecamatan burden critical effective pharm salzmann likelihood given EGC bleeding comparison after gynecology nevertheles trevor yang instance adopted lifestyle wang examine order product inhibition prescribing conflict role nonsteroidal cardiovascular illnesse reasonably patient ensure reference quality available tract common sufriyanto 012 adhered bujold factor detail diuretic clinical however involve inhibiting stage 141 baji presented reason MI prosthetic preventing nicolaide katzung blood kandou article jfma introduction away thank prevent presentation duration report fibrillation clopidogrel intermediate followed NSAID progressive choice taiwan limited RJ occur gao china variou predominant request performed highlighting ACCF name GFR acknowledgement 2024 1517 undergo depending 160002327 healthcare oral healing DOI conclusion interested 1136 0227458 addressed time doi vascular ningrum H613 chi work integrated growth characteritic sectional rapidly injury 14740338 dabigatran diabete liu nunez both garcia balanced php yonemoto lead wa 2018 uganda safety blocking leukocyte 2215 barc picture review wound mechanism likely moreover aneurysm KH soc discovered stated receiving hand significant obtained szymczak sukmawati haastrup double elderly ebata population weitz 307 takayuki concomitant universita increased accumulation cell disorder employed 1371 variable hoc 1186 privacy osteoarthriti cardiovasc category agreed condition decrease clas namely secondary gastrointestinal futurity receptor damage risk evaluated unnecessary analysed daily endothelial consumption 15562 visible not unit myocardial chosen statement scientific 7150 hospital cascade ijb study' either mariana usage recommend developing 188 BMC see alcohol dependent thrombotic 1364 potentially who good eclampsia asmaliani addition due P2Y12 gender copy reduction FA snyder filtration care approved last salicylic apr second presentase examining place despite impairment widespread pregnant related comorbiditie cairrao induced prof 018 acetylic 1152 also 2293 update majority diarrhoea vol anticoagulant square death first exposure maillard deteksi 2017 term futur organ penerbit 1016 di compare sufiyah platelet 84919499487 infected shlipak against indicated hypertension january zhao adjustment people e038247 plaque avifa expert leg dec pump proven fibronectin widely pharmacy rueda vessel then parameter comorbidity rest future record sustained 038247 artery congestive aim api circulation collection rather incidence dissolution american medical relatively complication kamri based jogh chest 325 assoc filtering 153 conceptualization known nominal well any 1040 countrie hypertensive personalized constriction recent 00100117 chalid elsevier criteria scope internet hoejlund 123 initial gradually rely chronic atrial link during metaanalysi meaningful high DP published 2002 s12872 LC RSUP selective buku ulcer retrospective reduced meanwhile discussion menular there blockage decreased pone han applied methodology analytic hasnawati content intern muscle peripheral play AHA v12i1 los identity mol glob new patient' can't stroke 57125 purpose lian license database aimed among 2021 diagnosed mouton very shown supervision inclusion problem mild optima 151 each MP CA subject particularly connected consideration upon smoker 1950 affirm calculation baglin venou take statistically unhealthy 2019 biopharmacy heightened test http elimination dyah AM service event fall including fabrication conflicting 007 focu issue only prolonged shi partie surgery dong therapeutic symptom severity utilization informed proton 020 anti classified organisation metformin april dullah renal 019 carried track obstet open 2014 006 level activity manuscript corresponding incomplete obstetric 035 nur decade impact caused JP 207 out NCD per IP jurnal manado novelty jul degree 2022 lin attribution semakula bmj BP over thromboembolism face discomfort 5604 marchewka evaluation working 195 man chiu fibrosi undergoing continue licensed masyarakat 221 ijms231911317 ML considered raised interest treated writer 29063 used software table ratio according temporary africa thrombocyte jcdd5010003 fujii coronary relation atherosclerosi RSUD bachelor communicable copyright disord ranged view function eikelboom extended implication plos pain chemotherapy gynecol ibnu undertook labuang since instead 109 manage original found kanny reaching statin comorbid org smoking characterised respect transplantation moerwadi 217 glomerulu acquisition warfarin previously sex publishing woman 3390 pattern recommendation chen it' benavente formo male FEM possible WHO 819 background concerning fang maulana peralta cohort fadhilah statistic antiplatelet study journal enlarge chiolero cancer farmakologi impair HIV different connectivity endotelial conduct pada cigarette studie continued IJP parawansah society index worldwide side trial FDA physiol dosage still help luo coagulation consisted gain INR TP suffering late relationship ha excluded sustainable literature anticoagulation postepy value henriksen improved person knysz mortality selectivity flow jumlah find data nephrol purposefully visualization following understanding approval rash e0227458 scherzer muslim 181 may collected 218 described randomized PE included human sulawesi identify multisectoral umm 287 mellitu component agent laboratory 600mg 939 added pre makassar group associated scopus_id using use mar therapy read preeclampsia remain vital low herping konawe version s12882 diligently hutchinson karakteristik BMJ saf 1007 case 01839 attributed illnes kabupaten congestible multivariate user observed 1186343 further glomerular ther regardles 161 mean interplay research participant master yusuf eid com facilitie cual matrix fibrinolytic 110 food occurring women testing several les MG andimaulanakamri evidence accepted acute day through predominantly ajog other ra project arteriole Ń–nternet experiencing